Bone Biologics Corporation

(PINK:BBLG)

Latest On Bone Biologics Corporation (BBLG):

Date/Time Type Description Signal Details
2022-10-07 11:55 ESTNewsBone Biologics prices $5.1M underwritten public offeringN/A
2022-03-07 14:43 ESTNewsBone Biologics inks supply deal with MTF Biologics for demineralized bone matrixN/A
2022-01-16 18:23 ESTNewsBone Biologics: Advancing Osteostimulative Recombinant Human Protein For Surgical ApplicationsN/A
2022-01-11 07:13 ESTNewsBone Biologics unexpectedly spikes 50% after presentation at Wainwright health conferenceN/A
2021-11-16 14:44 ESTNewsBone Biologics reports Q3 resultsN/A
2021-10-13 15:46 ESTNewsBone Biologics announces ~$8M stock offering, reverse stock splitN/A
2020-12-04 06:31 ESTFinancialsCompany financials have been released.Neutral
2020-11-27 00:54 ESTFinancialsCompany financials have been released.Neutral
2020-10-08 21:16 ESTFinancialsCompany financials have been released.Neutral
2020-10-04 15:32 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 16:43 ESTFinancialsCompany financials have been released.Neutral
2020-09-17 09:22 ESTFinancialsCompany financials have been released.Neutral
2020-08-14 12:48 ESTFinancialsCompany financials have been released.Neutral
2020-08-06 16:31 ESTFinancialsCompany financials have been released.Neutral
2020-08-04 19:48 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 12:11 ESTFinancialsCompany financials have been released.Neutral
2020-07-31 04:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 20:48 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 08:35 ESTFinancialsCompany financials have been released.Neutral
2020-07-30 00:54 ESTFinancialsCompany financials have been released.Neutral
2020-07-28 16:04 ESTFinancialsCompany financials have been released.Neutral
2020-07-27 16:29 ESTFinancialsCompany financials have been released.Neutral
2020-07-23 21:19 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 12:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-09 07:39 ESTFinancialsCompany financials have been released.Neutral
2020-07-03 07:17 ESTFinancialsCompany financials have been released.Neutral
2020-07-02 23:42 ESTFinancialsCompany financials have been released.Neutral
2020-07-02 07:16 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 20:19 ESTFinancialsCompany financials have been released.Neutral
2020-07-01 04:10 ESTFinancialsCompany financials have been released.Neutral
2020-06-29 23:18 ESTStock SplitA stock split has occured on Jul 24, 2018 with a split factor of 1:10.Neutral
2020-06-23 11:01 ESTInsider TradeDon Hankey has acquired 1,489,362 shares indirectly via Hankey Capital, LLC.Buy
2020-06-23 11:01 ESTInsider TradeDon Hankey has acquired 18,009,696 shares indirectly via Hankey Capital, LLC.Buy
2020-06-23 11:00 ESTInsider TradeBret Hankey has acquired 1,489,362 shares indirectly via HANKEY CAPITAL, LLC.Buy
2020-06-23 11:00 ESTInsider TradeBret Hankey has acquired 18,009,696 shares indirectly via HANKEY CAPITAL, LLC.Buy
2020-06-23 11:00 ESTInsider TradeBret Hankey has acquired 1,063,830 shares indirectly via Hankey Capital, LLC.Buy
2020-06-23 11:00 ESTInsider TradeDon Hankey has acquired 1,063,830 shares indirectly via Hankey Capital, LLC.Buy
2020-06-23 11:00 ESTInsider TradeBret Hankey has acquired 1,063,830 shares indirectly via Hankey Capital, LLC.Buy
2020-06-23 11:00 ESTInsider TradeDon Hankey has acquired 1,063,830 shares indirectly via Hankey Capital, LLC.Buy
2020-06-23 11:00 ESTInsider TradeBret Hankey has acquired 85,106 shares indirectly via HANKEY CAPITAL, LLC.Buy
2020-06-23 11:00 ESTInsider TradeDon Hankey has acquired 85,106 shares indirectly via Hankey Capital, LLC.Buy
2020-06-23 11:00 ESTInsider TradeDon Hankey has acquired 553,191 shares indirectly via Hankey Capital, LLC.Buy
2020-06-23 11:00 ESTInsider TradeBret Hankey has acquired 553,191 shares indirectly via Hankey Capital, LLC.Buy
2020-06-23 11:00 ESTInsider TradeDon Hankey has acquired 195,000 shares indirectly via Hankey Capital, LLC.Buy
2020-06-23 11:00 ESTInsider TradeBret Hankey has acquired 195,000 shares indirectly via Hankey Capital, LLC.Buy

About Bone Biologics Corporation (BBLG):

Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. Its NELL-1/DBX is a combination product, which is an osteostimulative recombinant protein that provides target specific control over bone regeneration. The company is developing NELL-1/DBX Fusion Device for spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L4-S1. The company's platform technology has application in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.

BBLG Quotes by TradingView

See Advanced Chart

General

  • Name Bone Biologics Corporation
  • Symbol BBLG
  • Type Common Stock
  • Exchange PINK
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Devices
  • Full Time Employees 1
  • Last Split Factor1:10
  • Last Split Date2018-07-24
  • Fiscal Year EndDecember
  • Web URLhttp://www.bonebiologics.com
View More

Financials

  • Most Recent Quarter 2019-12-31
  • Return on Assets -330%
  • Earnings Per Share -$0.62
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 230.12 million
  • EBITDA -2702413
  • Book Value Per Share -$0.36
View More

Share Statistics

  • Shares Outstanding 30.68 million
  • Shares Float 26.15 million
  • % Held by Insiders 1960%
View More

Technicals

  • Beta 0.09
  • 52 Week High $7.5
  • 52 Week Low $2.5
  • 50 Day Moving Average 7.5
  • 200 Day Moving Average 5.64
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Bone Biologics Corporation (BBLG) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Bone Biologics Corporation (BBLG) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2019-12-312019-12-31$N/A-$0.02
2019-09-302019-09-30$N/A-$0.08
2019-06-302019-06-30$N/A-$0.13
2019-03-312019-03-31$N/A-$0.19
2018-12-312018-12-31$N/A-$0.06
2018-09-302018-09-30$N/A-$0.03
2018-06-302018-06-30$N/A-$0.29
2018-03-312018-03-31$N/A-$0.33
2017-12-312017-12-31$N/A-$0.60
2017-09-302017-09-30$N/A-$0.65
2017-06-302017-06-30$N/A$0.21
2017-03-312017-03-31$N/A-$0.79
2016-12-312016-12-31$N/A-$1.26
2016-09-302016-09-30-$1.13
2016-06-302016-06-30-$1.26
2016-03-312016-03-31-$2.01

Bone Biologics Corporation (BBLG) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date Dec 31 2019 Sep 30 2019 Jun 30 2019 Mar 31 2019 Dec 31 2018
Research Development 68336 44942 417565 564333 549437
Income Before Tax -531183 -561380 -923952 -1.41 million -1.47 million
Selling General Administrative 209293 256368 261692 624904 689369
Gross Profit N/A N/A N/A N/A N/A
Ebit -277629 -301310 -679231 -1.19 million -1.24 million
Operating Income -277629 -301310 -679257 -1.19 million -1.24 million
Income Tax Expense -36 39 1600 N/A 122
Total Revenue N/A N/A N/A N/A N/A
Cost of Revenue N/A N/A N/A N/A N/A
Total Other Income Expense Net N/A 119097 -244695 -217456 -231760
Net Income From Continuing Operations -531147 -561419 -925552 -1.41 million -1.47 million
Net Income Applicable to Common Shares -531147 -561419 -925552 -1.41 million -1.47 million
Cash Flow:
Date Dec 31 2019 Sep 30 2019 Jun 30 2019 Mar 31 2019 Dec 31 2018
Investments N/A N/A N/A N/A N/A
Change to Liabilities -121586 -5021 -335109 396892 64093
Total Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Net Borrowings 120000 500000 1000000 700000 700000
Total Cash Flow from Financial Activities 120000 500000 1000000 700000 700000
Change to Operating Activities 55829 436679 -331534 47632 20824
Change in Cash -177689 25462 -550035 -228967 -1.34 million
Total Cash from Operating Activities -297689 -474538 -1.55 million -928967 -1.34 million
Depreciation N/A N/A 26 24 24
Other Cash Flow from Investing Activities N/A N/A N/A N/A N/A
Change to Inventory N/A N/A N/A N/A N/A
Change to Account Receivables N/A N/A N/A N/A N/A
Other Cash Flow from Financing Activities N/A N/A N/A N/A N/A
Change to Net Income 299215 -344777 42134 33178 47003
Capital Expenditures N/A N/A N/A N/A N/A
Balance Sheet:
Date Dec 31 2019 Sep 30 2019 Jun 30 2019 Mar 31 2019 Dec 31 2018
Total Liabailities 11.9 million 11.63 million 11.12 million 10.79 million 9.64 million
Total Stockholder Equity -11.87 million -11.38 million -10.86 million -9.97 million -8.6 million
Other Current Liabilities N/A 85143 80767 76392 72017
Total Assets 30827 249345 266395 814089 1.04 million
Common Stock 30682 30682 30066 27938 26449
Other Current Assets N/A N/A N/A N/A N/A
Retained Earnings -67.04 million -66.51 million -65.95 million -65.02 million -63.62 million
Other Liabilities N/A N/A N/A N/A N/A
Other Assets N/A N/A N/A N/A N/A
Cash 24145 201834 176372 726407 955374
Total Current Liabilities 578447 11.63 million 11.12 million 10.79 million 9.64 million
Other Stockholder Equity N/A N/A N/A N/A N/A
Property, Plant & Equipment N/A N/A N/A 26 50
Total Current Assets 30827 249345 266395 814063 1.04 million
Long Term Investments N/A N/A N/A N/A N/A
Net Tangible Assets -11.87 million -11.38 million -10.86 million -9.97 million -8.6 million
Short Term Investments N/A N/A N/A N/A N/A
Long Term Debt 11.32 million N/A N/A N/A N/A
Inventory N/A N/A N/A N/A N/A
Accounts Payable 42879 137612 178236 517720 125203

Bone Biologics Corporation (BBLG) Chart:

Bone Biologics Corporation (BBLG) News:

Below you will find a list of latest news for Bone Biologics Corporation (BBLG) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Bone Biologics Corporation (BBLG) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Bone Biologics Corporation (BBLG) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1419554/000149315220004977/0001493152-20-004977-index.htm
2018-07-253Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000125085318000104/0001250853-18-000104-index.htm
2018-07-263Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000125085318000106/0001250853-18-000106-index.htm
2018-07-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419554/000149315218010202/0001493152-18-010202-index.htm
2018-07-23DNotice of Exempt Offering of Securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315218010351/0001493152-18-010351-index.htm
2018-07-25SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1419554/000149315218010434/0001493152-18-010434-index.htm
2018-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419554/000149315218010971/0001493152-18-010971-index.htm
2018-08-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1419554/000149315218011302/0001493152-18-011302-index.htm
2018-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419554/000149315218011715/0001493152-18-011715-index.htm
2018-09-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419554/000149315218013300/0001493152-18-013300-index.htm
2018-11-14NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/1419554/000149315218016147/0001493152-18-016147-index.htm
2018-11-1610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419554/000149315218016378/0001493152-18-016378-index.htm
2019-03-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419554/000149315219003809/0001493152-19-003809-index.htm
2019-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315219003931/0001493152-19-003931-index.htm
2019-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315219003934/0001493152-19-003934-index.htm
2019-03-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1419554/000149315219003937/0001493152-19-003937-index.htm
2019-03-2910-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1419554/000149315219004221/0001493152-19-004221-index.htm
2019-04-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419554/000149315219005443/0001493152-19-005443-index.htm
2019-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315219005760/0001493152-19-005760-index.htm
2019-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419554/000149315219006965/0001493152-19-006965-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315219008226/0001493152-19-008226-index.htm
2019-05-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315219008227/0001493152-19-008227-index.htm
2019-05-24SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1419554/000149315219008228/0001493152-19-008228-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315219009559/0001493152-19-009559-index.htm
2019-06-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315219009561/0001493152-19-009561-index.htm
2019-06-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1419554/000149315219009562/0001493152-19-009562-index.htm
2019-06-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419554/000149315219009880/0001493152-19-009880-index.htm
2019-07-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1419554/000149315219010722/0001493152-19-010722-index.htm
2019-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315219010724/0001493152-19-010724-index.htm
2019-07-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315219010727/0001493152-19-010727-index.htm
2019-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315219011866/0001493152-19-011866-index.htm
2019-08-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315219011867/0001493152-19-011867-index.htm
2019-08-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1419554/000149315219011869/0001493152-19-011869-index.htm
2019-08-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419554/000149315219012340/0001493152-19-012340-index.htm
2019-09-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419554/000149315219014537/0001493152-19-014537-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1419554/000149315219017251/0001493152-19-017251-index.htm
2020-01-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1419554/000149315220000387/0001493152-20-000387-index.htm
2020-01-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315220000773/0001493152-20-000773-index.htm
2020-01-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1419554/000149315220000776/0001493152-20-000776-index.htm
2020-01-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1419554/000149315220000780/0001493152-20-000780-index.htm
2020-03-3010-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1419554/000149315220004977/0001493152-20-004977-index.htm

Bone Biologics Corporation (BBLG) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bone Biologics Corporation (BBLG). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1960%
Institutional Ownership: < 1%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-07-15Bret HankeyDirectorBuy85,106.000.00https://www.sec.gov/Archives/edgar/data/1419554/000149315219010724/0001493152-19-010724-index.htm
2019-06-20Don HankeyChairman of the BoardBuy1,063,830.000.00https://www.sec.gov/Archives/edgar/data/1419554/000149315219009561/0001493152-19-009561-index.htm
2018-12-17Bret HankeyDirectorBuy18,009,696.0023,013,754.00https://www.sec.gov/Archives/edgar/data/1419554/000149315219003934/0001493152-19-003934-index.htm
2018-12-17Don HankeyChairman of the BoardBuy18,009,696.0024,210,421.00https://www.sec.gov/Archives/edgar/data/1419554/000149315219003931/0001493152-19-003931-index.htm
2019-03-25Bret HankeyDirectorBuy1,489,362.0025,063,903.00https://www.sec.gov/Archives/edgar/data/1419554/000149315219003934/0001493152-19-003934-index.htm
2019-03-25Don HankeyChairman of the BoardBuy1,489,362.0025,699,783.00https://www.sec.gov/Archives/edgar/data/1419554/000149315219003931/0001493152-19-003931-index.htm
2019-05-07Bret HankeyDirectorBuy1,063,830.0026,127,733.00https://www.sec.gov/Archives/edgar/data/1419554/000149315219008226/0001493152-19-008226-index.htm
2019-05-07Don HankeyChairman of the BoardBuy1,063,830.0026,763,613.00https://www.sec.gov/Archives/edgar/data/1419554/000149315219008227/0001493152-19-008227-index.htm
2019-06-20Bret HankeyDirectorBuy1,063,830.0027,191,563.00https://www.sec.gov/Archives/edgar/data/1419554/000149315219009559/0001493152-19-009559-index.htm
2019-08-06Bret HankeyDirectorBuy553,191.0027,829,860.00https://www.sec.gov/Archives/edgar/data/1419554/000149315219011867/0001493152-19-011867-index.htm
2019-07-15Don HankeyChairman of the BoardBuy85,106.0027,912,549.00https://www.sec.gov/Archives/edgar/data/1419554/000149315219010727/0001493152-19-010727-index.htm
2020-01-02Bret HankeyDirectorBuy195,000.001.00195,000.0028,122,518.00https://www.sec.gov/Archives/edgar/data/1419554/000149315220000776/0001493152-20-000776-index.htm
2019-08-06Don HankeyChairman of the BoardBuy553,191.0028,465,740.00https://www.sec.gov/Archives/edgar/data/1419554/000149315219011866/0001493152-19-011866-index.htm
2020-01-02Don HankeyChairman of the BoardBuy195,000.001.00195,000.0028,563,398.00https://www.sec.gov/Archives/edgar/data/1419554/000149315220000773/0001493152-20-000773-index.htm